治疗耐药抑郁症的Esketamine:一个案例系列和文献综述
Muhammad Abbas1, David B Adams1, Jack Noto1
1Psychiatry, Hackensack Meridian School of Medicine, Nutley, USA.
Cureus
|October 14, 2025
概括
埃斯凯特胺在治疗耐药性抑郁症 (TRD) 患者中表现有前途,这些患者没有对电疗法 (ECT) 产生反应. 虽然在长期内并不普遍有效,但它为难以治愈的病例提供了希望.
科学领域:
- 神经科学是一个神经科学.
- 精神病学是一个精神病学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 耐治疗抑郁症 (TRD) 在实现缓解方面存在重大挑战.
- 电疗法 (ECT) 是TRD的积极治疗方法,但并不总是成功.
- 对于那些 ECT 失败的患者,治疗选择有限.
研究的目的:
- 评估ESKETAMINE在TRD患者的真实有效性,这些患者有失败的ECT史.
- 分析病例报告和关于在这个特定患者群体中使用埃斯基他明的文献.
主要方法:
- 追溯分析来自单一护理中心的四份病例报告.
- 包括文献综述,以将发现置于背景.
- 叙述讨论埃斯基坦胺的潜在治疗作用.
主要成果:
- 四分之三的患者经历了显著的症状改善与esketamine.
- 一名患者尽管之前ECT失败,但获得了有效的长期治疗.
- 副作用在某些情况下限制了胺胺的长期效用.
结论:
- 乙胺是一些TRD患者的可行的替代治疗方法.
- 它甚至为那些对ECT没有反应的人提供了潜在的治疗选择.
- 进一步的研究是有必要的,以优化esketamine的使用和管理副作用.
相关概念视频
Electroconvulsive Therapy
891
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
891
Antidepressant Drugs: MAOIs and Other Agents
823
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
823
Psychosis: Goals of Pharmacotherapy
469
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
469
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
1.4K
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
1.4K
Antidepressant Drugs: Overview
1.4K
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
1.4K
Drug Therapy
242
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
242


